Imatinib mesylate (Gleevec) for disease relapse following allogeneic bone marrow transplantation.

被引：0
|
作者：
Soiffer, RJ [1 ]
Galinsky, I [1 ]
DeAngelo, D [1 ]
Alyea, EP [1 ]
Antin, JH [1 ]
Restas, D [1 ]
Stone, RM [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1682
引用
收藏
页码：400A / 400A
页数：1
相关论文
共 50 条
  • [1] Bone marrow lymphoid reconstitution following allogeneic bone marrow transplantation.
    Hasserjian, RP
    Horncastle, DE
    Nasher, ST
    LABORATORY INVESTIGATION, 1999, 79 (01) : 138A - 138A
  • [2] Imatinib mesylate in the treatment of relapse of chronic myeloid leukemia after allogeneic stem sell transplantation.
    Zhu, KG
    Zhang, T
    Chen, J
    Zhong, J
    BLOOD, 2005, 106 (11) : 291B - 291B
  • [3] Imatinib mesylate for the treatment of relapse of chronic myeloid leukaemia after allogeneic stem cell transplantation.
    Olavarria, E
    Fischer, T
    Ottmann, O
    Clark, R
    Bandini, G
    Byrne, J
    Lipton, J
    Niederwieser, D
    Goldman, J
    BLOOD, 2002, 100 (11) : 329B - 329B
  • [4] Imatinib Mesylate (Gleevec®) And Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Rivaud, E.
    Tcherakian, C.
    Metivier, A. -C.
    Neveu, H.
    Vernant, J. P.
    Couderc, L. J.
    Dhedin, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [5] Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec) - Bone marrow histopathology and correlation with genetic status
    Frater, JL
    Tallman, MS
    Variakojis, D
    Druker, BJ
    Resta, D
    Riley, MB
    Hrisinko, MA
    Peterson, LC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (06) : 833 - 841
  • [6] Pure red cell aplasia following allogeneic bone marrow transplantation.
    Barta, A
    Batai, A
    Torbagyi, E
    Gopcsa, L
    Petranyi, GG
    Kelemen, E
    Paloczi, K
    BONE MARROW TRANSPLANTATION, 1998, 21 : S52 - S52
  • [7] Skeletal changes occur rapidly following allogeneic bone marrow transplantation.
    Krueger, D
    Flynn, B
    Vallarta-Ast, N
    Smith, EP
    Atkinson, ME
    Longo, WL
    Binkley, N
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S420 - S420
  • [8] The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation
    Conchon, Monika
    Sanabani, Sabri S.
    Bendit, Israel
    Dinardo, Carla Luana
    Dias, Lucia
    Fischer Chamone, Dalton de Alencar
    Dorlhiac-Llacer, Pedro Enrique
    Dulley, Frederico Luiz
    JOURNAL OF TRANSPLANTATION, 2009, 2009
  • [9] Allogeneic peripheral blood progenitor cell infusion for treatment of relapse after allogeneic bone marrow transplantation.
    Dreger, P
    Haferlach, T
    Winkemann, T
    Suttorp, M
    Loffler, H
    Schmitz, N
    BLOOD, 1995, 86 (10) : 1156 - 1156
  • [10] Comparison of hematopoietic recovery following allogeneic blood stem cell transplantation and allogeneic bone marrow transplantation.
    Bishop, MR
    Tarantolo, SR
    MartinAlgarra, S
    Cowles, K
    Bierman, PJ
    Vose, JM
    Reed, EC
    Gross, TG
    Armitage, JO
    Pavletic, ZS
    Nasrati, K
    Kessinger, A
    BLOOD, 1995, 86 (10) : 1553 - 1553
12345